WETEX 2025 Welcomes Strong Line-up of 68 Local and International Sponsors

30.9.2025 07:50:00 CEST | Business Wire | Press Release

Under the directives of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, and under the patronage of HH Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Supreme Council of Energy, Dubai Electricity and Water Authority (DEWA) organises the 27th Water, Energy, Technology and Environment Exhibition (WETEX) from 30 September to 2 October 2025 at the Dubai World Trade Centre.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250929065969/en/

HE Saeed Mohammed Al Tayer, Vice Chairman of the Dubai Supreme Council of Energy and Chairman of the Emirates Energy Award (photo: AETOSWire)

WETEX 2025 has attracted 68 sponsors and 18 partners and supporters. A total of 3,100 companies from 65 countries are taking part in the exhibition, which includes 18 international pavilions and covers an area of 95,000 square metres.

“Our constructive co-operation and strategic partnership with the exhibition's sponsors play a vital role in reinforcing WETEX’s global standing and enhancing its impact as a key milestone on the path to a sustainable future,” said HE Saeed Mohammed Al Tayer, MD&CEO of DEWA, Founder and Chairman of WETEX.

Premier Sponsor

OMNIYAT Group

Principal Sponsors

Roads and Transport Authority (RTA), Dubai
MASDAR
TAQA
Riyadh Cables Group
Emirates National Oil Company (ENOC)
Dragon Oil
Siemens – UAE and the Middle East
Siemens Energy
ACWA Power

Titanium Sponsors

BinGhatti
DAMAC Properties
Dubai Cable Company (DUCAB)

Platinum Sponsors

Jeddah Cables Company, part of the Energya Group
AG Power
Hitachi Energy – UAE
HD Hyundai Electric
Centaur Group
SUNTEN
Tesar SRL
Larsen & Toubro

Strategic Sponsors

Emirates Central Cooling Systems Corporation PJSC (Empower)
SAP
Gulf Eternit Industries
National Cables Industry
Saeed Juma Al Naboodah Group
DANWAY
ARAR Group
Etihad Water and Electricity
Voltamp Energy SAOG
Green Oasis General Contracting Company
Alfanar
Emirates Transformers & Switchgear Limited
Emirates Water and Electricity Company
Federal Electricals

Strategic Media Sponsors

Dubai Media
Forbes Middle East
CNBC Arabia
Arabian Radio Network

Gold Sponsors

Lucy Middle East
Power Plus Cable Co
Itron
BEST
Emirates Global Aluminium
AASA MIDDLE EAST CONTRACTING CO
Trillium Flow Technologies
Afaq Al Khaleej Engineering Resources
Torishima Service Solutions
GECO Mechanical & Electrical Co
Ellington Properties
Schweitzer Engineering Laboratories (SEL)
Maetel Instalaciones y Servicios Industriales-SA (Dubai branch)
Ingram Micro Gulf
SOUEAST UAE
Khansaheb Group
S R Intelligent Technologies Consultancy
Fortinet
BINGHALIB GROUP OF COMPANIES
Dubai Taxi Company
GAMA Security Systems
Leadership Roundtable Sponsor
PwC Middle East

Source: AETOSWire

View source version on businesswire.com: https://www.businesswire.com/news/home/20250929065969/en/

Contacts

Shaikha Almheiri
+971552288228

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom